A research study comparing different ways of increasing the dose of NNC0519-0130 in participants with overweight or obesity
NN9541-7760
Phase 1 other active
Quick answer
A research study comparing different ways of increasing the dose of NNC0519-0130 in participants with overweight or obesity for Type 2 diabetes mellitus is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Type 2 diabetes mellitus
- Phase
- Phase 1
- Modality
- other
- Status
- active